NNI Nelnet Forecast, Technical & Fundamental Analysis

NNI's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for NNI turned positive on November 26, 2025. Looking at past instances where NNI's MACD turned positive, the stock continued to rise in of 54 cases over the following month. The odds of a continued upward trend are .

Technical Analysis (Indicators)

Bullish Trend Analysis

NNI moved above its 50-day moving average on November 25, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where NNI advanced for three days, in of 275 cases, the price rose further within the following month. The odds of a continued upward trend are .

NNI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 282 cases where NNI Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

The Momentum Indicator moved below the 0 level on November 28, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on NNI as a result. In of 96 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The 10-day moving average for NNI crossed bearishly below the 50-day moving average on November 20, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NNI declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 73, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.278) is normal, around the industry mean (12.325). P/E Ratio (10.909) is within average values for comparable stocks, (37.314). NNI's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.381). Dividend Yield (0.009) settles around the average of (0.183) among similar stocks. P/S Ratio (3.517) is also within normal values, averaging (128.698).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. NNI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.